WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2000028981) METHODS FOR TREATING, PREVENTING, AND REDUCING THE RISK OF THE ONSET OF ALZHEIMER'S DISEASE USING AN HMG COA REDUCTASE INHIBITOR
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2000/028981    International Application No.:    PCT/US1999/026979
Publication Date: 25.05.2000 International Filing Date: 15.11.1999
Chapter 2 Demand Filed:    12.06.2000    
IPC:
A61K 31/00 (2006.01), A61K 31/22 (2006.01), A61K 31/366 (2006.01), A61K 31/40 (2006.01), A61K 31/404 (2006.01), A61K 31/4418 (2006.01)
Applicants: NYMOX CORPORATION [CA/CA]; Suite 306 9900 Cavendish Boulevard Saint Laurent, Quebec H4M 2V2 (CA) (For All Designated States Except US).
WOLOZIN, Benjamin [US/CA]; (CA) (For US Only)
Inventors: WOLOZIN, Benjamin; (CA)
Agent: BENT, Stephen, A.; Foley & Lardner Suite 500 3000 K Street, NW Washington, DC 20007-5109 (US)
Priority Data:
09/190,439 13.11.1998 US
Title (EN) METHODS FOR TREATING, PREVENTING, AND REDUCING THE RISK OF THE ONSET OF ALZHEIMER'S DISEASE USING AN HMG COA REDUCTASE INHIBITOR
(FR) METHODES DE TRAITEMENT, DE PREVENTION ET DE REDUCTION DU RISQUE D'APPARITION DE LA MALADIE D'ALZHEIMER UTILISANT UN INHIBITEUR DE LA HMG-COA REDUCTASE
Abstract: front page image
(EN)Described are methods for treating, preventing, or reducing the risk of the onset of Alzheimer's disease by administering a therapeutically effective amount of an inhibitor of the enzyme 3-hydroxy-3-methylglutaryl coenzyme A reductase ('HMG CoA reductase inhibitor') to a patient who is at risk for a coronary or cerebrovascular event or at risk for Alzheimer's disease.
(FR)La présente invention concerne des méthodes de traitement, de prévention ou de réduction du risque d'apparition de la maladie d'Alzheimer, consistant à administrer à un patient susceptible de subir un accident coronaire ou cérébro-vasculaire ou de développer la maladie d'Alzheimer, une dose efficace sur le plan thérapeutique d'un inhibiteur de 3-hydroxy-3-méthylglutaryl-coenzymeA réductase ('HMG-CoA reductase inhibitor').
Designated States: AE, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CU, CZ, DE, DK, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)